These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7509391)

  • 1. Gallium arsenide-induced increase in serum corticosterone is not responsible for suppression of the IgM antibody response.
    Burns LA; Spriggs TL; Fuchs BA; Munson AE
    J Pharmacol Exp Ther; 1994 Feb; 268(2):740-6. PubMed ID: 7509391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splenic cell targets in gallium arsenide-induced suppression of the primary antibody response.
    Sikorski EE; Burns LA; Stern ML; Luster MI; Munson AE
    Toxicol Appl Pharmacol; 1991 Aug; 110(1):129-42. PubMed ID: 1871769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. I. Pharmacokinetics after in vitro and in vivo exposure.
    Burns LA; Munson AE
    J Pharmacol Exp Ther; 1993 Apr; 265(1):144-9. PubMed ID: 8386233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. II. Nature and identification of reversing factors.
    Burns LA; Munson AE
    J Pharmacol Exp Ther; 1993 Apr; 265(1):150-8. PubMed ID: 8474002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for arsenic as the immunosuppressive component of gallium arsenide.
    Burns LA; Sikorski EE; Saady JJ; Munson AE
    Toxicol Appl Pharmacol; 1991 Aug; 110(1):157-69. PubMed ID: 1651571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of splenic accessory cell function in mice exposed to gallium arsenide.
    Sikorski EE; Burns LA; McCoy KL; Stern M; Munson AE
    Toxicol Appl Pharmacol; 1991 Aug; 110(1):143-56. PubMed ID: 1714636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of gallium arsenide-induced suppression of the antibody response by a mixed disulfide metabolite of meso-2,3-dimercaptosuccinic acid.
    Burns LA; Butterworth LF; Munson AE
    J Pharmacol Exp Ther; 1993 Feb; 264(2):695-700. PubMed ID: 8382280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallium arsenide selectively suppresses antigen processing by splenic macrophages for CD4+ T cell activation.
    Lewis TA; Munson AE; McCoy KL
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1244-51. PubMed ID: 8819508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotoxicity of the semiconductor gallium arsenide in female B6C3F1 mice.
    Sikorski EE; McCay JA; White KL; Bradley SG; Munson AE
    Fundam Appl Toxicol; 1989 Nov; 13(4):843-58. PubMed ID: 2695379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallium arsenide selectively inhibits T cell proliferation and alters expression of CD25 (IL-2R/p55).
    Burns LA; Munson AE
    J Pharmacol Exp Ther; 1993 Apr; 265(1):178-86. PubMed ID: 8097242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct exposure to gallium arsenide upregulates costimulatory activity of murine macrophages.
    Caffrey-Nolan RE; McCoy KL
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):330-9. PubMed ID: 9707509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallium arsenide augments antigen processing by peritoneal macrophages for CD4+ helper T cell stimulation.
    Hartmann CB; McCoy KL
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):365-72. PubMed ID: 8975760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic in the sera of gallium arsenide-exposed mice inhibits bacterial growth and increases host resistance.
    Burns LA; McCay JA; Brown R; Munson AE
    J Pharmacol Exp Ther; 1993 May; 265(2):795-800. PubMed ID: 8496824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the immune system in rats and mice administered linear ammonium perfluorooctanoate.
    Loveless SE; Hoban D; Sykes G; Frame SR; Everds NE
    Toxicol Sci; 2008 Sep; 105(1):86-96. PubMed ID: 18559402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Toxicology and Carcinogenesis Studies of Gallium Arsenide (CAS No. 1303-00-0) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2000 Sep; 492():1-306. PubMed ID: 12563348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the primary humoral immune response following exposure of male rats to 17beta-estradiol or flutamide for 15 days.
    Ladics GS; Smith C; Nicastro SC; Loveless SE; Cook JC; O'Connor JC
    Toxicol Sci; 1998 Nov; 46(1):75-82. PubMed ID: 9928670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallium arsenide selectively up-regulates inflammatory cytokine expression at exposure site.
    Becker SM; McCoy KL
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1045-53. PubMed ID: 14560044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gallium arsenide modulates proteolytic cathepsin activities and antigen processing by macrophages.
    Lewis TA; Hartmann CB; McCoy KL
    J Immunol; 1998 Sep; 161(5):2151-7. PubMed ID: 9725206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymic atrophy caused by ethanol in a mouse model for binge drinking: involvement of endogenous glucocorticoids.
    Han YC; Lin TL; Pruett SB
    Toxicol Appl Pharmacol; 1993 Nov; 123(1):16-25. PubMed ID: 8236255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotoxicological characteristics of sodium methyldithiocarbamate.
    Pruett SB; Barnes DB; Han YC; Munson AE
    Fundam Appl Toxicol; 1992 Jan; 18(1):40-7. PubMed ID: 1601208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.